Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response
BackgroundPost-acute sequelae of SARS-CoV-2 infection (PASC), also known as post-COVID-19 condition (here abbreviated as post-COVID) is an escalating global health issue. The aim of our study was to investigate the mechanisms and clinical manifestations of post-COVID following a mild SARS-CoV-2 infe...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589589/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689028659511296 |
|---|---|
| author | Serena Fineschi Serena Fineschi Joakim Klar Juan Ramon Lopez Egido Jens Schuster Jonas Bergquist Jonas Bergquist René Kaden René Kaden Niklas Dahl |
| author_facet | Serena Fineschi Serena Fineschi Joakim Klar Juan Ramon Lopez Egido Jens Schuster Jonas Bergquist Jonas Bergquist René Kaden René Kaden Niklas Dahl |
| author_sort | Serena Fineschi |
| collection | DOAJ |
| description | BackgroundPost-acute sequelae of SARS-CoV-2 infection (PASC), also known as post-COVID-19 condition (here abbreviated as post-COVID) is an escalating global health issue. The aim of our study was to investigate the mechanisms and clinical manifestations of post-COVID following a mild SARS-CoV-2 infection.MethodsWe analyzed the gene expression profile in PBMCs from 60 middle-aged post-COVID patients and 50 age-matched controls at a median time of 28 months following a mild SARS-CoV-2 infection. The clinical assessments included intensity of post-COVID symptoms, physical and mental fatigue, depression and anxiety. Sixty-seven participants performed a mild exertion ergometer test with assessment of lactate concentrations. Transcriptome analysis was performed on mRNA selected by poly-A enrichment and SARS-CoV-2 RNA fragments were analyzed using the ARTIC protocol.ResultsWe identified 463 differentially expressed transcripts in PBMCs, of which 324 were upregulated and 129 downregulated in post-COVID patients. Upregulated genes in post-COVID individuals were enriched for processes involving JAK-STAT signaling, negative regulation of ubiquitination, IL9 signaling, and negative regulation of viral process, suggesting chronic inflammation. Downregulated genes were enriched for processes involving mitochondrial ATP synthesis, and oxidative phosphorylation, suggesting mitochondrial dysfunction. No SARS-CoV-2 gene fragments were detected in PBMCs of patients with post-COVID and no IFN genes were found differentially expressed in post-COVID patients. Post-COVID was associated with elevated lactate levels in blood, both at rest and after a short recovery phase following exertion, suggesting increased anaerobic activity in skeletal muscles. We did not find differences in the transcriptional profiles or clinical manifestations when comparing patients who contracted the infection from early SARS-CoV-2 variants with those who contracted the infection during the period when the Omicron variant was prevalent.ConclusionsOur findings highlight molecular changes compatible with a persistent immune response in PBMCs of post-COVID subjects at a median follow-up of 28 months after a mild infection, supporting the hypothesis that post-COVID is a chronic inflammatory condition. The upregulation of JAK/STAT signaling suggests a potential therapeutic target in post-COVID. |
| format | Article |
| id | doaj-art-602ea7529fac45df8c4b5d3d49bc8115 |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-602ea7529fac45df8c4b5d3d49bc81152025-08-20T03:21:46ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15895891589589Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune responseSerena Fineschi0Serena Fineschi1Joakim Klar2Juan Ramon Lopez Egido3Jens Schuster4Jonas Bergquist5Jonas Bergquist6René Kaden7René Kaden8Niklas Dahl9Department of Public Health and Caring Sciences, Faculty of Medicine, Uppsala University, Uppsala, SwedenÖsthammar Health Care Centre, Östhammar, SwedenScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenÖsthammar Health Care Centre, Östhammar, SwedenScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenAnalytical Chemistry and Neurochemistry, Department of Chemistry, Biomedicinskt Centrum (BMC), Uppsala University, Uppsala, SwedenThe ME/CFS Collaborative Research Centre, Uppsala University, Uppsala, SwedenDepartment of Medical Sciences, Uppsala University, Akademiska Sjukhuset, Uppsala, SwedenClinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, SwedenScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenBackgroundPost-acute sequelae of SARS-CoV-2 infection (PASC), also known as post-COVID-19 condition (here abbreviated as post-COVID) is an escalating global health issue. The aim of our study was to investigate the mechanisms and clinical manifestations of post-COVID following a mild SARS-CoV-2 infection.MethodsWe analyzed the gene expression profile in PBMCs from 60 middle-aged post-COVID patients and 50 age-matched controls at a median time of 28 months following a mild SARS-CoV-2 infection. The clinical assessments included intensity of post-COVID symptoms, physical and mental fatigue, depression and anxiety. Sixty-seven participants performed a mild exertion ergometer test with assessment of lactate concentrations. Transcriptome analysis was performed on mRNA selected by poly-A enrichment and SARS-CoV-2 RNA fragments were analyzed using the ARTIC protocol.ResultsWe identified 463 differentially expressed transcripts in PBMCs, of which 324 were upregulated and 129 downregulated in post-COVID patients. Upregulated genes in post-COVID individuals were enriched for processes involving JAK-STAT signaling, negative regulation of ubiquitination, IL9 signaling, and negative regulation of viral process, suggesting chronic inflammation. Downregulated genes were enriched for processes involving mitochondrial ATP synthesis, and oxidative phosphorylation, suggesting mitochondrial dysfunction. No SARS-CoV-2 gene fragments were detected in PBMCs of patients with post-COVID and no IFN genes were found differentially expressed in post-COVID patients. Post-COVID was associated with elevated lactate levels in blood, both at rest and after a short recovery phase following exertion, suggesting increased anaerobic activity in skeletal muscles. We did not find differences in the transcriptional profiles or clinical manifestations when comparing patients who contracted the infection from early SARS-CoV-2 variants with those who contracted the infection during the period when the Omicron variant was prevalent.ConclusionsOur findings highlight molecular changes compatible with a persistent immune response in PBMCs of post-COVID subjects at a median follow-up of 28 months after a mild infection, supporting the hypothesis that post-COVID is a chronic inflammatory condition. The upregulation of JAK/STAT signaling suggests a potential therapeutic target in post-COVID.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589589/fullpost-COVIDSARS-CoV-2RNA sequencingJAK/STAT signalinginterferon signatureubiquitination |
| spellingShingle | Serena Fineschi Serena Fineschi Joakim Klar Juan Ramon Lopez Egido Jens Schuster Jonas Bergquist Jonas Bergquist René Kaden René Kaden Niklas Dahl Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response Frontiers in Immunology post-COVID SARS-CoV-2 RNA sequencing JAK/STAT signaling interferon signature ubiquitination |
| title | Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response |
| title_full | Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response |
| title_fullStr | Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response |
| title_full_unstemmed | Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response |
| title_short | Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response |
| title_sort | comprehensive transcriptome assessment in pbmcs of post covid patients at a median follow up of 28 months after a mild covid infection reveals upregulation of jak stat signaling and a prolonged immune response |
| topic | post-COVID SARS-CoV-2 RNA sequencing JAK/STAT signaling interferon signature ubiquitination |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589589/full |
| work_keys_str_mv | AT serenafineschi comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT serenafineschi comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT joakimklar comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT juanramonlopezegido comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT jensschuster comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT jonasbergquist comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT jonasbergquist comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT renekaden comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT renekaden comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse AT niklasdahl comprehensivetranscriptomeassessmentinpbmcsofpostcovidpatientsatamedianfollowupof28monthsafteramildcovidinfectionrevealsupregulationofjakstatsignalingandaprolongedimmuneresponse |